Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

This article has been updated

Abstract

Maternal HIV-1–specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Matched IgG, but not mismatched IgG, affects plasma viral load in SHIVSF162P3- infected infant macaques.
Figure 2: Matched IgG, but not mismatched IgG, improves humoral responses up to 24 weeks after infection.

Similar content being viewed by others

Change history

  • 29 December 2010

     In the version of this article initially published, the original received date was 27 April 2007. The correct received date is 27 April 2010. The error has been corrected in the HTML version of the article.

References

  1. Richman, D.D., Wrin, T., Little, S.J. & Petropoulos, C.J. Proc. Natl. Acad. Sci. USA 100, 4144–4149 (2003).

    Article  CAS  Google Scholar 

  2. Steimer, K.S., Scandella, C.J., Skiles, P.V. & Haigwood, N.L. Science 254, 105–108 (1991).

    Article  CAS  Google Scholar 

  3. Li, Y. et al. Nat. Med. 13, 1032–1034 (2007).

    Article  CAS  Google Scholar 

  4. Burton, D.R. et al. Science 266, 1024–1027 (1994).

    Article  CAS  Google Scholar 

  5. Wu, X. et al. J. Virol. 80, 835–844 (2006).

    Article  CAS  Google Scholar 

  6. Shibata, R. et al. Nat. Med. 5, 204–210 (1999).

    Article  CAS  Google Scholar 

  7. Mascola, J.R. et al. Nat. Med. 6, 207–210 (2000).

    Article  CAS  Google Scholar 

  8. Baba, T.W. et al. Nat. Med. 6, 200–206 (2000).

    Article  CAS  Google Scholar 

  9. Hessell, A.J. et al. PLoS Pathog. 5, e1000433 (2009).

    Article  Google Scholar 

  10. Hessell, A.J. et al. Nat. Med. 15, 951–954 (2009).

    Article  CAS  Google Scholar 

  11. Forthal, D.N., Landucci, G., Phan, T.B. & Becerra, J. J. Virol. 79, 2042–2049 (2005).

    Article  CAS  Google Scholar 

  12. Forthal, D.N. et al. J. Virol. 80, 9217–9225 (2006).

    Article  CAS  Google Scholar 

  13. Haigwood, N.L. et al. J. Virol. 78, 5983–5995 (2004).

    Article  CAS  Google Scholar 

  14. Yamamoto, H., Kawada, M., Takeda, A., Igarashi, H. & Matano, T. PLoS ONE 2, e540 (2007).

    Article  Google Scholar 

  15. Jayaraman, P. et al. J. Virol. 81, 822–834 (2007).

    Article  CAS  Google Scholar 

  16. Hessell, A.J. et al. Nature 449, 101–104 (2007).

    Article  CAS  Google Scholar 

  17. Moir, S. et al. J. Exp. Med. 205, 1797–1805 (2008).

    Article  CAS  Google Scholar 

  18. Walker, L.M. et al. Science 326, 285–289 (2009).

    Article  CAS  Google Scholar 

  19. Wu, X. et al. Science 329, 856–861 (2010).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Z. Brower for technical support, D. Morris and K. Filer for manuscript preparation, M.L. Marthas and K.K.A. Van Rompay for advice on subcutaneous dosing of IgG and oral inoculation of infants, J. Overbaugh (Fred Hutchinson Cancer Research Center) for the Env-deleted viral backbone plasmid Q23ΔEnv, S. Barnett and I. Srinivasan (Novartis) for recombinant gp120-SF162 and V. Planelles (University of Utah) for the plasmid pEMC*. M. Piatak and J.D. Lifson (Science Applications International Corporation) kindly provided RNA standards and advice on real-time PCR. SHIVSF162P3 was supplied by N. Miller (US National Institutes of Health Division of AIDS) and R. Pal (Advanced Bioscience Labs). TZM-bl were supplied by the US National Institutes of Health AIDS Research Reference Reagent Program. This study was supported by grants from the US National Institutes of Health R01HD038653 (N.L.H.), R01AI33292 (D.R.B.) and R01AI052039 (D.N.F.) and from the Elizabeth Glaser Pediatric AIDS Foundation (N.L.H.).

Author information

Authors and Affiliations

Authors

Contributions

C.T.N., J.P.J., W.F.S. and G.L. were responsible for experimental work, analyses and preparation of figures; P.D. and L.K. provided macaque care and clinical and laboratory assessments; D.A. oversaw the study at the Washington National Primate Research Center; C.T.N., D.N.F., D.R.B., D.A. and P.J. contributed to the writing of the manuscript; B.A.R. performed the statistical analyses; D.R.B. provided IgG1b12; N.L.H. was responsible for study design and coordination and writing the manuscript.

Corresponding author

Correspondence to Nancy L Haigwood.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–7, Supplementary Table 1 and Supplementary Methods (PDF 360 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ng, C., Jaworski, J., Jayaraman, P. et al. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat Med 16, 1117–1119 (2010). https://doi.org/10.1038/nm.2233

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2233

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing